Y
Yuehan Zhang
Researcher at Johns Hopkins University
Publications - 15
Citations - 414
Yuehan Zhang is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 7, co-authored 11 publications receiving 290 citations.
Papers
More filters
Journal ArticleDOI
The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer
Carole Fakhry,William H. Westra,Steven J. Wang,Annemieke van Zante,Yuehan Zhang,Eleni M. Rettig,Linda X. Yin,William R. Ryan,Patrick K. Ha,Alicia Wentz,Wayne M. Koch,Jeremy D. Richmon,David W. Eisele,Gypsyamber D'Souza +13 more
TL;DR: Survival differences were explored by the tumor HPV status among patients with OPSCCs by sex and race and patients with nonoropharyngeal (non‐OP) head and neck squamous cell cancers (HNSCCs).
Journal ArticleDOI
Sex Differences in Risk Factors and Natural History of Oral Human Papillomavirus Infection
Gypsyamber D'Souza,Alicia Wentz,Nicole Kluz,Yuehan Zhang,Elizabeth A. Sugar,Renee M. Youngfellow,Yingshi Guo,Weihong Xiao,Maura L. Gillison +8 more
TL;DR: In a cohort study of oral HPV infection among 409 individuals aged 18-25 years, the risk among men but not among women significantly increased as the number of recent (ie, within the prior 3 months) oral sex partners increased (Pinteraction).
Journal ArticleDOI
Projected Association of Human Papillomavirus Vaccination With Oropharynx Cancer Incidence in the US, 2020-2045.
TL;DR: In this article, a population-based age-period-cohort analysis obtained Oropharynx cancer (OPC) incidence data from the Surveillance, Epidemiology, and End Results program from 69 562 patients 34 to 83 years of age diagnosed with OPC.
Journal ArticleDOI
Patient experience and anxiety during and after treatment for an HPV-related oropharyngeal cancer.
Gypsyamber D'Souza,Yuehan Zhang,Samantha Merritt,Dorothy Gold,Hilary A. Robbins,Victoria Buckman,Jennifer E. Gerber,David W. Eisele,Patrick K. Ha,Patrick K. Ha,Joseph A. Califano,Carole Fakhry +11 more
TL;DR: After treatment, some HPV-OPC patients remain concerned about HPV and have unanswered questions about HPV.
Journal ArticleDOI
Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment.
Yuehan Zhang,Tim Waterboer,Robert I. Haddad,Brett A. Miles,Alicia Wentz,Neil D. Gross,Carole Fakhry,Harry Quon,Jochen H. Lorch,Christine G. Gourin,Daniel R. Clayburgh,Krzysztof Misiukiewicz,Jeremy D. Richmon,Peter E. Andersen,Marshall R. Posner,Gypsyamber D'Souza +15 more
TL;DR: The high seroprevalence of HPV oncogenic antibodies at diagnosis of HPV-OPC is confirmed, and HPV16 E6 antibody levels decrease after treatment, but most cases remain seropositive for up to two years.